Show simple item record

dc.contributor.authorNacu, Alionaen_US
dc.contributor.authorAndersen, Jintana Bunpanen_US
dc.contributor.authorLisnic, Vitalieen_US
dc.contributor.authorOwe, Jone Furulunden_US
dc.contributor.authorGilhus, Nils Eriken_US
dc.PublishedAutoimmunity 2015, 48(6):362-368eng
dc.description.abstractMyasthenia gravis (MG) is a rare autoimmune disease of skeletal muscle endplates. MG subgroup is relevant for comorbidity, but usually not accounted for. MG patients have an increased risk for complicating autoimmune diseases, most commonly autoimmune thyroid disease, systemic lupus erythematosus and rheumatoid arthritis. In this review, we present concomitant autoimmune disorders associated with the different MG subgroups, and show how this influences treatment and prognosis. Concomitant MG should always be considered in patients with an autoimmune disorder and developing new neuromuscular weakness, fatigue or respiratory failure. When a second autoimmune disorder is suspected, MG should be included as a differential diagnosis.en_US
dc.publisherTaylor & Franciseng
dc.rightsAttribution CC BY 4.0eng
dc.subjectAutoimmune diseaseeng
dc.subjectMyasthenia graviseng
dc.titleComplicating autoimmune diseases in myasthenia gravis: A reviewen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2015 The Author(s)
dc.subject.nsiVDP::Matematikk og Naturvitenskap: 400en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY 4.0
Except where otherwise noted, this item's license is described as Attribution CC BY 4.0